175 related articles for article (PubMed ID: 36474126)
61. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
62. Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma.
Sun Q; Burton R; Reddy V; Lucas KG
Br J Haematol; 2002 Sep; 118(3):799-808. PubMed ID: 12181048
[TBL] [Abstract][Full Text] [Related]
63. Reappraisal of nodal Epstein-Barr Virus-negative cytotoxic T-cell lymphoma: Identification of indolent CD5
Yamashita D; Shimada K; Takata K; Miyata-Takata T; Kohno K; Satou A; Sakakibara A; Nakamura S; Asano N; Kato S
Cancer Sci; 2018 Aug; 109(8):2599-2610. PubMed ID: 29845715
[TBL] [Abstract][Full Text] [Related]
64. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
[TBL] [Abstract][Full Text] [Related]
65. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency.
Hauck F; Randriamampita C; Martin E; Gerart S; Lambert N; Lim A; Soulier J; Maciorowski Z; Touzot F; Moshous D; Quartier P; Heritier S; Blanche S; Rieux-Laucat F; Brousse N; Callebaut I; Veillette A; Hivroz C; Fischer A; Latour S; Picard C
J Allergy Clin Immunol; 2012 Nov; 130(5):1144-1152.e11. PubMed ID: 22985903
[TBL] [Abstract][Full Text] [Related]
66. Novel Compound Heterozygous ZAP70 R37G A507T Mutations in Infant with Severe Immunodeficiency.
Benavides N; White JC; Sanmillan ML; Thomas M; Le T; Caywood E; Giraudo CG
J Clin Immunol; 2023 Dec; 44(1):27. PubMed ID: 38129328
[TBL] [Abstract][Full Text] [Related]
67. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
68. Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.
Zhong L; Wang W; Ma M; Gou L; Tang X; Song H
Medicine (Baltimore); 2017 Oct; 96(42):e7989. PubMed ID: 29049190
[TBL] [Abstract][Full Text] [Related]
69. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
70. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
71. Age-related EBV-associated B-cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti-PD-L1 antibody clone SP142.
Sakakibara A; Kohno K; Ishikawa E; Suzuki Y; Shimada S; Eladl AE; Elsayed AA; Daroontum T; Satou A; Takahara T; Ohashi A; Takahashi E; Kato S; Nakamura S; Asano N
Pathol Int; 2020 Aug; 70(8):481-492. PubMed ID: 32367595
[TBL] [Abstract][Full Text] [Related]
72. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
[TBL] [Abstract][Full Text] [Related]
73. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature.
Petrilli G; Lorenzi L; Paracchini R; Ubiali A; Schumacher RF; Cabassa P; Facchetti F
Int J Surg Pathol; 2014 Dec; 22(8):712-21. PubMed ID: 21454372
[TBL] [Abstract][Full Text] [Related]
74. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
75. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency.
Mosier DE; Gulizia RJ; Baird SM; Spector S; Spector D; Kipps TJ; Fox RI; Carson DA; Cooper N; Richman DD
Curr Top Microbiol Immunol; 1989; 152():195-9. PubMed ID: 2553338
[TBL] [Abstract][Full Text] [Related]
76. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
Ballow M; Sánchez-Ramón S; Walter JE
Front Immunol; 2022; 13():928062. PubMed ID: 35924244
[TBL] [Abstract][Full Text] [Related]
77. New Presentation of CD27 Deficiency; Coronary Ectasia and COVID-19.
Golchehre Z; Sharafian S; Momtazmanesh N; Chavoshzadeh Z; Karimi A; Abolhassani H; Kazemi Aghdam M; Vahidshahi K; Hashemimoghaddam S; Kosari F; Khafafpour Z; Shamsian BS; Keramatipour M
Iran J Allergy Asthma Immunol; 2023 Feb; 22(1):110-118. PubMed ID: 37002625
[TBL] [Abstract][Full Text] [Related]
78. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
[TBL] [Abstract][Full Text] [Related]
79. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
Kingma DW; Shad A; Tsokos M; Fest T; Otsuki T; Frekko K; Werner E; Werner A; Magrath I; Raffeld M; Jaffe ES
Am J Surg Pathol; 1996 Dec; 20(12):1511-9. PubMed ID: 8944045
[TBL] [Abstract][Full Text] [Related]
80. Antibodies to CD40 prevent Epstein-Barr virus-mediated human B-cell lymphomagenesis in severe combined immune deficient mice given human peripheral blood lymphocytes.
Murphy WJ; Funakoshi S; Beckwith M; Rushing SE; Conley DK; Armitage RJ; Fanslow WC; Rager HC; Taub DD; Ruscetti FW
Blood; 1995 Sep; 86(5):1946-53. PubMed ID: 7544649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
